Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryosuke Ochiai

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Cancer Science|August 26, 2022
Plasma exosomal DOK3 reflects immunological states in lung tumor and predicts prognosis of gefitinib treatmentRyosuke Ochiai, Kentaro Hayashi, Hiroshi Yamamoto, et al.
Case Reports in Oncology|February 23, 2019
Promising Combination Therapy with Bevacizumab and Erlotinib in an EGFR-Mutated NSCLC Patient with MET Amplification Who Showed Intrinsic Resistance to Initial EGFR-TKI TherapyNobuhiko Seki, Maika Natsume, Ryosuke Ochiai, et al.
Cancers|February 27, 2026
Prognostic Impact of Baseline Neutrophil-to-Lymphocyte Ratio and Its On-Treatment Change on Survival Outcomes in Advanced Small-Cell Lung Cancer: A Retrospective AnalysisMasashi Ishihara, Hao Chen, Reina Asaga, et al.
Case Reports in Oncology|February 23, 2019
Successful Treatment with Taxane-Based Chemotherapy in Advanced Sebaceous Carcinoma: A Case Report and Literature ReviewShuji Ota, Takahiko Sakamoto, Ryosuke Ochiai, et al.
Nature Communications|September 18, 2020
The lysophospholipase D enzyme Gdpd3 is required to maintain chronic myelogenous leukaemia stem cellsKazuhito Naka, Ryosuke Ochiai, Eriko Matsubara, et al.
Case Reports in Oncology|February 23, 2019
Significance of Earlier Initiation of Chemotherapy for Lung Cancer Complicated with Primary or Secondary Nephrotic Syndrome following Its Appropriate Differential DiagnosisShuji Ota, Yoshihide Fujigaki, Yoshifuru Tamura, et al.
Internal Medicine (Tokyo, Japan)|November 26, 2019
Importance and Difficulty of Differentiating BMA-induced AFF Prodromal Symptoms from Hormonal Therapy-related Femoral PainShuji Ota, Toru Tokizaki, Masakazu Sugimoto, et al.
Japanese Journal of Clinical Oncology|April 10, 2024
A single arm Phase I/II trial on the combination of carboplatin, nab-paclitaxel and avastin as first-line treatment for advanced non-squamous non-small cell lung cancer (TORG1424/OLCSG1402: CARNAVAL)Naoyuki Nogami, Toshio Kubo, Akihiro Bessho, et al.
Bioanalysis|October 18, 2021
Highlights of the 12th Japan Bioanalysis Forum SymposiumHitoshi Uchiyama, Takeru Yamaguchi, Koji Arai, et al.
Heliyon|May 26, 2023
A strategy for low-cost portable monitoring of plasma drug concentrations using a sustainable boron-doped-diamond chipTakuro Saiki, Genki Ogata, Seishiro Sawamura, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cancer Science|August 26, 2022
Plasma exosomal DOK3 reflects immunological states in lung tumor and predicts prognosis of gefitinib treatmentRyosuke Ochiai, Kentaro Hayashi, Hiroshi Yamamoto, et al.
Case Reports in Oncology|February 23, 2019
Promising Combination Therapy with Bevacizumab and Erlotinib in an EGFR-Mutated NSCLC Patient with MET Amplification Who Showed Intrinsic Resistance to Initial EGFR-TKI TherapyNobuhiko Seki, Maika Natsume, Ryosuke Ochiai, et al.
Cancers|February 27, 2026
Prognostic Impact of Baseline Neutrophil-to-Lymphocyte Ratio and Its On-Treatment Change on Survival Outcomes in Advanced Small-Cell Lung Cancer: A Retrospective AnalysisMasashi Ishihara, Hao Chen, Reina Asaga, et al.
Case Reports in Oncology|February 23, 2019
Successful Treatment with Taxane-Based Chemotherapy in Advanced Sebaceous Carcinoma: A Case Report and Literature ReviewShuji Ota, Takahiko Sakamoto, Ryosuke Ochiai, et al.
Nature Communications|September 18, 2020
The lysophospholipase D enzyme Gdpd3 is required to maintain chronic myelogenous leukaemia stem cellsKazuhito Naka, Ryosuke Ochiai, Eriko Matsubara, et al.
Case Reports in Oncology|February 23, 2019
Significance of Earlier Initiation of Chemotherapy for Lung Cancer Complicated with Primary or Secondary Nephrotic Syndrome following Its Appropriate Differential DiagnosisShuji Ota, Yoshihide Fujigaki, Yoshifuru Tamura, et al.
Internal Medicine (Tokyo, Japan)|November 26, 2019
Importance and Difficulty of Differentiating BMA-induced AFF Prodromal Symptoms from Hormonal Therapy-related Femoral PainShuji Ota, Toru Tokizaki, Masakazu Sugimoto, et al.
Japanese Journal of Clinical Oncology|April 10, 2024
A single arm Phase I/II trial on the combination of carboplatin, nab-paclitaxel and avastin as first-line treatment for advanced non-squamous non-small cell lung cancer (TORG1424/OLCSG1402: CARNAVAL)Naoyuki Nogami, Toshio Kubo, Akihiro Bessho, et al.
Bioanalysis|October 18, 2021
Highlights of the 12th Japan Bioanalysis Forum SymposiumHitoshi Uchiyama, Takeru Yamaguchi, Koji Arai, et al.
Heliyon|May 26, 2023
A strategy for low-cost portable monitoring of plasma drug concentrations using a sustainable boron-doped-diamond chipTakuro Saiki, Genki Ogata, Seishiro Sawamura, et al.
Pageof 3